About Richard Malley
Richard Malley was a director of AI3 Bio, Inc., a company developing therapies that eliminate the T cells driving autoimmune disease.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Richard Malley in the role, so the role may have started earlier or lasted longer.
AI3 Bio, Inc.
Director
2025 · Watertown, MA
ai3Bio develops lipid nanoparticle and antibody drugs that remove the T cells driving autoimmune disease, for patients living with these conditions.
Key Colleagues at Startups
The people Richard Malley works with at each company, as listed on that company's latest Form D.
AI3 Bio, Inc. · Form D, Oct 20, 2025
AE
Alan Ezekowitz
Board Director
NS
Nick Seaver
CFO/CBO, Board Director
Jonathan Kagan
Distinguished Scientist and director
Steven Altschuler
CEO, Board Director
AB
Andrew Bellinger
Director
AC
Andrew Cornforth
Executive officer
NG
Nichols Garrett
Executive officer